Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Arena Pharmaceuticals
- ID
- NCT04556734
- Phase
- Phase 2 Alopecia Areata Research Study
- Study Type
- Interventional
- Participants
- Expecting 78 study participants
- Last Updated